Skip to main content
logo
Verona Pharma plc (VRNA)
Oct 7, 2025 - VRNA was delisted (reason: acquired by MRK)
106.91
+0.12 (0.11%)
Inactive · Last trade price on Oct 6, 2025

Verona Pharma Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingJun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Revenue
221.6742.28-0.4640-
Revenue Growth
----98.86%--
Gross Profit
210.9339.7-0.1140-
Operating Income
-53.85-151.03-66.47-66.12-57.68-66.01
Net Income
-81.19-173.42-54.37-68.7-55.57-65.15
Earnings Per Share
-1.03-2.16-0.72-1.04-0.94-1.98
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingJun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Investments
438.02399.76271.77227.83148.38187.99
Total Debt
244.37228.8151.3310.655.815.95
Net Cash (Debt)
193.64170.95220.44217.18142.57182.04
Net Cash Growth
-31.43%-22.45%1.50%52.33%-21.68%360.33%
Net Cash Per Share
2.312.102.783.282.415.54

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingJun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Cash Flow
-72.49-122.2-50.22-59.86-33.25-45.08
Capital Expenditures
-1.07-0.58--0.03-0.01-0.08
Free Cash Flow
-73.56-122.78-50.22-59.89-33.27-45.16
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingJun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Gross Margin
95.15%93.89%-24.45%100.00%-
Operating Margin
-24.29%-357.22%--14435.81%-144.21%-
Pretax Margin
-32.91%-385.84%--14944.98%-138.97%-
Profit Margin
-36.63%-410.18%--15000.22%-138.92%-
FCF Margin
-33.18%-290.41%--13076.64%-83.17%-

Valuation
Chart
Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingAug '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
PS Ratio
40.3989.89-4657.4011.09-